Newsfeeds - Spark Newswire

2 minute read

Why Novavax Looks Like It’s Breaking Out Of A Pattern

Today, 5:50 PM

Novavax Inc. (NASDAQ: NVAX) shares are rallying after the company announced it finalized an advanced purchase agreement with the European Commission for the purchase of up to 200 million doses of its

NVAX

2 minute read

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 5:50 PM

AEMD

1 minute read

Novavax, Serum Institute Of India Report Submission To World Health Organization For Emergency Use Listing Of Co.’s COVID-19 Vaccine

By Benzinga Newsdesk

Today, 5:50 PM

Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine GAITHERSBURG, Md., Sept. 23,

NVAX

2 minute read

British Study To Test Mixed COVID-19 Vaccine Regime In Kids: Reuters

By Vandana Singh

Today, 5:50 PM

A British study will be launched to assess the mixed COVID-19 vaccine shots in children, Reuters reported. The study,…

BNTX

5 minute read

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera’s COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

By Shanthi Rexaline

Today, 5:50 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)

ABCL

1 minute read

Novavax Sees Prevent-19 Phase 3 Trial Participants Considered Fully Vaccinated, In Compliance With Mandated Vaccination Policies

By Benzinga Newsdesk

Today, 5:50 PM

-Reuters

NVAX

2 minute read

Why Moderna, BioNTech, Novavax And Pfizer Are Trading Lower

By Shanthi Rexaline

Today, 5:50 PM

Coronavirus vaccine stocks Pfizer Inc. (NYSE: PFE), Moderna, Inc.

BNTX

2 minute read

Moderna Shares Gain Amid R&D Day Presentations: What You Need To Know

By Shanthi Rexaline

Today, 5:50 PM

Moderna, Inc. (NASDAQ: MRNA), a biotech that rose to prominence with its successful coronavirus vaccine program, is holding its fifth annual R&D day Thursday.

AZN